Novo Nordisk A/S Common Stock (NVO)

Investing Cash Flow

-kr 12.76B

Quarterly · Period ending: · DKK

NVO logo

NVO Investing Cash Flow

Latest reported-kr 12.76B DKK
NVO Quarterly Cash from Investing · DKK (kr 531.70M → -kr 12.76B)
High-resolution chart · PNG

NVO investing cash flow history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Investing Cash Flow — Quarterly (DKK)
Period endingInvesting Cash Flow (DKK)
-12,764,000,000
-11,712,000,000
-42,812,000,000
-15,425,000,000
-14,248,000,000
-6,673,000,000
-91,216,000,000
-20,904,000,000
-20,731,000,000
3,956,000,000
-14,717,000,000
-13,243,000,000
-9,285,000,000
-6,647,000,000
-13,850,000,000
-4,961,000,000
-4,200,000,000
-1,907,000,000
-20,603,000,000
-4,635,000,000
-2,886,000,000
-3,481,000,000
-12,900,000,000
-6,063,000,000
-1,367,000,000
-2,106,000,000
-3,209,000,000
-2,441,000,000
-2,833,000,000
-3,026,000,000
-4,099,000,000
-2,864,000,000
-2,543,000,000
-2,574,000,000
-3,163,000,000
-1,991,000,000
-725,000,000
-692,000,000
-2,731,000,000
-2,677,000,000
224,000,000
-1,606,000,000
-4,695,000,000
-3,302,000,000
57,000,000
1,842,000,000
-1,577,000,000
-1,034,000,000
131,000,000
416,000,000
-521,000,000
-1,999,000,000
140,000,000
-393,000,000
-1,617,000,000
-1,776,000,000
672,000,000
-1,349,000,000
-2,532,000,000
-602,000,000
-220,000,000
-105,000,000
-3,611,000,000
-865,000,000
-781,000,000
-322,000,000
-1,181,000,000
-797,000,000
-546,000,000
-522,000,000
-321,077,450
-467,213,550
-328,029,150
-269,122,650
152,534,000
-609,727,950
-615,185,650
-446,478,400
-796,738,670
-836,113,730
-770,348,350
-116,966,850
-2,237,163,440
-1,165,647,200
-771,777,430
-729,908,370
-1,206,133,620
-893,201,510
-446,386,260
531,695,120
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.